ADP Form 4: Director Executes Multiple Sales via 10b5-1 Plan
Rhea-AI Filing Summary
Carlos A. Rodriguez, a director of Automatic Data Processing, Inc. (ADP), reported multiple open-market sales of ADP common stock on 09/05/2025 executed under a Rule 10b5-1 trading plan adopted in September 2024. The Form 4 lists a sequence of dispositions at prices between $294.3246 and $302.4519 per share. Following the reported transactions the filing shows 25,361.4431 shares held directly and 13,813 shares held indirectly through a trust. The form was signed by a power of attorney, David Kwon, on 09/08/2025. The filing discloses only sales activity; no derivative transactions were reported.
Positive
- Sales executed under a disclosed Rule 10b5-1 plan, providing an affirmative defense framework
- Full Form 4 disclosure including transaction dates, prices, and post-transaction holdings
- Power of attorney signature present with filing date, supporting procedural completeness
Negative
- Director disposed of a portion of direct holdings, reducing direct shares to 25,361.4431
- No information on total number of shares sold aggregated in the filing (only individual trades listed)
Insights
TL;DR: Multiple pre-arranged sales under a 10b5-1 plan reduced a director's direct ADP holdings; no new derivatives or exceptions disclosed.
The reported transactions are explicit sales executed under a documented Rule 10b5-1 plan, which provides an affirmative defense to insider trading claims when properly adopted and followed. The sale prices range from approximately $294.32 to $302.45 per share, and the director's direct ownership declined to 25,361.4431 shares while retaining 13,813 shares indirectly via a trust. For investors, this filing documents routine liquidity by an insider rather than any announced corporate action; the material facts reported are limited to the sales and the existence of the trading plan.
TL;DR: Disclosure aligns with Section 16 timing and cites a previously adopted 10b5-1 plan; presentation appears procedurally compliant.
The Form 4 clearly identifies the reporting person, relationship to the issuer (director), and that transactions were made pursuant to a 10b5-1 plan adopted in September 2024. Signature by a power of attorney is present with a 09/08/2025 date. The filing reports only non-derivative sales; there is no amendment indicated. From a governance perspective, the form contains the necessary elements for transparency under Section 16 and does not assert any exceptions or undisclosed arrangements beyond the stated plan.